期刊文献+

环氧化酶-2在婴幼儿血管瘤中的表达 被引量:4

The role of COX-2 in dermal hemangioma of infant
原文传递
导出
摘要 目的通过研究婴幼儿血管瘤组织中环氧化酶-2(COX-2)蛋白的表达情况,进一步探讨和分析COX-2在婴幼儿血管瘤组织中表达情况与婴幼儿血管瘤的发生、发展可能存在的一些相关性。方法收集蚌埠医学院第一附属医院病理科2010—2012年婴幼儿患者手术后血管瘤组织标本和术后同期瘤旁正常血管组织标本各52例,应用免疫组织化学SP法,分别对52例婴幼儿血管瘤及52例瘤旁正常血管组织标本表达情况进行免疫组织化检测,2组间的比较采用χ2检验。结果 COX-2在52例婴幼儿血管瘤中的表达阳性率为88.46%,且多为强阳性,以(++)为主。而COX-2在婴幼儿瘤旁正常血管组织中的表达阳性率为17.31%,且着色较弱,为(+)。婴幼儿血管瘤组织中环氧化酶-2(COX-2)表达与瘤旁正常血管组织中COX-2表达相比较差异具有统计学意义(P<0.05)。结论 COX-2在婴幼儿血管瘤组织中的表达呈明显增高,COX-2在婴幼儿血管瘤组织中的表达与婴幼儿血管瘤的发生、发展有一定相关性;研究COX-2在婴幼儿血管瘤血管内皮细胞上表达情况有可能为临床婴幼儿血管瘤疾病的诊断、治疗及婴幼儿血管瘤的下一步研究提供了一种新思路。 Objective To investigate the role of COX-2 in dermal hemangioma of infant. Methods 52 cases of infantile hemangiomas tissue specimens and peritumoral normal vascular tissue specimens over the same period were recruited in our department of pathology from 2010 to 2012 in bengbu medical college's first hospital. The expression of COX-2 was observed in the 52 hemangiomas of infant and 52 normal vascular tissue by immunohistochemistry. Statistical analysis were performed using χ2test between the two groups. Results The positive rate of COX-2 in hemangiomas was 88. 46% and in normal vascular tissue was 17. 31%. The comparison between these two groups had statistical significance( P〈0. 05). Conclusion The expression of COX-2 in dermal hemangioma was significantly higher than in normal vascular tissue. The higher expression COX-2 in hemangiomas of infant could stimulate the development of hemangioma; the expression COX-2 in normal vascular tissue was low. It could provide a new concept to clinic diagnose and therapy for hemangiomas of infant and a new way for next step research to investigate the role of COX-2 in dermal hemangioma of infant.
出处 《中华全科医学》 2014年第7期1032-1034,共3页 Chinese Journal of General Practice
基金 蚌埠医学院课题(BY1042)
关键词 血管瘤 婴幼儿 环氧化酶-2 Hemangioma Infant COX-2
  • 相关文献

参考文献16

  • 1Sadeghi-Aliabadi H,Aliasgharluo M,Fattahi A,et al.In vitro cytotoxic evaluation of some synthesized COX-2 inhibitor derivatives against a panel of human cancer cell lines [ J ].Res Pharm Sci,2013,8(4):298-303. 被引量:1
  • 2薛雷,王绪凯.血管内皮细胞生长因子和环氧化酶-2在血管瘤中表达的研究[J].中国实用口腔科杂志,2010,3(11):667-669. 被引量:1
  • 3金云波,林晓曦,马刚,陈辉,李伟,范新东,林梅绥,王维,周兆平,王炜.不消退型先天性血管瘤的诊断和治疗研究[J].中华整形外科杂志,2009,25(3):189-193. 被引量:12
  • 4袁斯明,邢新,欧阳天祥,倪灿荣,杨志勇,张敬德.婴幼儿血管瘤病理演变过程中形态观察[J].临床与实验病理学杂志,2005,21(3):290-294. 被引量:15
  • 5Lee NO,Park JW,Lee JA,et al.Dual action of a selective cyclooxyge-nase-2 inhibitor on vascular endothelial growth factor expression in hu-man hepatocellular carcinoma cells:novel involvement of discoidin do-main receptor 2 [ J ].J Cancer Res Clin Oncol,2012,138(1):73-84. 被引量:1
  • 6Ma JX,Sun YL,Wang YQ,et al.Tfiptolide induces apoptosis and in-hibits the growth and angiogenesis of human pancreatic cancer cells by downregnlating COX-2 and VEGF[ J ].Oncol Res,2013,20(8):359-368. 被引量:1
  • 7Kargi A,Uysal M,Bozeuk H,et al.The importance of COX-2 expres-sion as prognostic factor in early breast cancer[J].J BUON,2013,18(3):579-584. 被引量:1
  • 8张志坤,李淑静,高秀江,朱振龙,陈浩.胃肠道腺癌组织中HIF-1α、COX-2的表达及意义[J].中国煤炭工业医学杂志,2012,15(7):996-998. 被引量:1
  • 9Sturgeon CM,Duffy M J,Stenman UH,et al.National Academy of Clin-ical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular,prostate,colorectal,breast,and ovarian cancers [ J ].Clin Chem,2008,54(12):11-79. 被引量:1
  • 10Mulliken JB,Enjolras O.Congenital hemangiomas and infantile he-mangioma:missing links [ J ].J Am Acad Dermatol,2004,50(6):875-882. 被引量:1

二级参考文献51

  • 1王绪凯.脉管性疾病的治疗[J].中国实用口腔科杂志,2009,2(5):280-282. 被引量:24
  • 2王琳琳,朱炎.血管内皮生长因子在口腔恶性肿瘤研究中的进展[J].口腔颌面外科杂志,2006,16(1):87-90. 被引量:10
  • 3中华病理学杂志编辑委员会.《全国免疫组织化学技术与诊断标准化专题研讨会》会议纪要[J].中华病理学杂志,1996,25(6):326-328. 被引量:40
  • 4Boon LM, Enjolras O, Mulliken JB. Congenital hemangioma:evidence for accelerated involution. J Pediatr, 1996, 128(3):329-335. 被引量:1
  • 5Berenguer B, Mulliken JB, Enjolras O, et al. Rapidly involuting congenital hemangioma:clinical and histopathologic features. Pediatr Develop Pathol, 2003, 6(6) :495-510. 被引量:1
  • 6Enjolras O, Muniken JB, Boon LM, et al. Non-involuting congenital hemangioma : a rare cutaneous vascular anomaly. Plast Reconstr Surg, 2001, 107(7) :1647-1654. 被引量:1
  • 7Enjolras O, Mulliken JB. Vascular tumors and vascular malformations (new issues). Adv Dermatol, 1997, 13:375-423. 被引量:1
  • 8MuUiken JB, Glawacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg, 1982, 69(3):412-422. 被引量:1
  • 9Takahashi K, Mulliken JB, Kozakewich HP, et al. Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest, 1994, 93(6) :2357-2364. 被引量:1
  • 10Vikkula M, Boon LM, Mulliken JB, et al. Molecular basis of vascular anomalies. Trends Cardiovasc Med, 1998, 8(7):281-292. 被引量:1

共引文献24

同被引文献24

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部